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December 20121828 AbstractsTable 3. 30-day/in-hospital and late adverse events
Variable
Thoracic endovascular
aortic repair (N47)
Death
30-day death 0 (0%)
Late death 8 (17%)
Aorta-related deaths 0 (0%)
Stroke 1 (2%)
Permanent paraplegia/paraparesis 1 (2%)
Acute renal failure (Cr2.0 and 2 times
baseline Cr)
4 (9%)
New-onset dialysis 2 (4%)
Prolonged mechanical ventilation (48 hours) 3 (6%)
Myocardial ischemia 0 (0%)
Postoperative length of stay (IQR), days 5 (3–7)
Reintervention 13 (28%)
Open 3 (23%)
Endovascular 10 (77%)
Median time to reintervention (IQR), months 4.5 (1.4–8.1)
Median time to follow-up/death (IQR), months 33.4 (13.6–55.2)
Cr, Creatinine; IQR, interquartile range
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Introduction:We have previously described our early experience using
retrograde laser fenestration to revascularize the left subclavian artery (LSA)
during zone II thoracic endovascular aortic repair (TEVAR). This technique
uses a relatively simple intraoperative method of endograft modification to
revascularize aortic branches for a variety of acute thoracic aortic patholo-
gies. The aim of this study is to present our expanded experience and
L
tidterm outcomes of TEVAR with laser fenestration to revascularize the
SA as an alternative to debranching.
Methods: A retrospective review of the electronic medical records was
onducted of all patients who underwent TEVAR with LSA revasculariza-
ion via laser graft fenestration from September 2009 through August 2012.
EVAR was carried out with deployment of a Dacron endograft over the
rifice of the LSA. Through retrograde brachial access, a 0.018-inch guide-
ire was placed at the ostium of the LSA, followed by laser catheter
enestration of the graft. Balloon-expandable covered stents were deployed
hrough the fenestration to traverse the endograft and LSA; the endograft
ortion of the covered stent was flared. Routine postoperative follow-up
maging with computed tomography angiography was performed to assess
or TEVAR and LSA fenestration patency, endoleak, and aneurysm/dissec-
ion exclusion.
Results: TEVAR with laser fenestration was successfully performed in
2 patients (12 men; mean age, 57 years; range, 37-83 years) in an urgent or
mergency setting secondary to unremitting symptoms. Thirteen patients
ad large symptomatic thoracic aortic aneurysms (10 secondary to chronic
issection); four patients had acute symptomatic type B aortic dissection,
nd five patients had intramural hematoma or penetrating aortic ulcer. An
verage of two endografts (range, 1-4) were placed during TEVAR. LSA-
overed stents ranged from 8 to 10mm in diameter.Mean operative time for
EVAR with laser fenestration was 154 65 minutes. The average hospital
ength of stay was 12  7 days. There were no fenestration-related compli-
ations. One patient developed postoperative paraplegia, and one patient
ied of massive hemoptysis in the postoperative period, for an in-hospital
ortality rate of 4.5%. At a mean follow-up of 8 months (range, 1-32
onths), two patients had died (9%) of non–TEVAR-related causes. Follow
p computed tomography angiography imaging demonstrated a 100%
rimary patency for the LSA stents. One patient had an asymptomatic LSA
tent stenosis. Two patients had type II endoleaks from the LSA that
equired reintervention. Both were successfully managed with endovascular
oil embolization. There were no fenestration-related type I or III
ndoleaks.
Conclusions: In situ retrograde laser fenestration is a feasible and
ffective option for LSA revascularization during TEVAR involving a spec-
rum of acute thoracic aortic pathologies. Laser fenestration provides a rapid,
eproducible method of fenestrating the endograft material. The high
echnical success, low fenestration-related morbidity, and excellent midterm
atency support this technique of intraoperative endograft modification.
onger follow-up remains necessary to determine the durability of this
echnique.
